Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases

Clinical and Translational Oncology

Volumn 9, Issue 9, 2007, Pages 590-595

  Conill, C ^a   Berenguer, J ^a   Vargas, M ^a   Lopez Soriano A ^a   Valduvieco, I ^a   Marruecos, J ^a   Vilella, R ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Central nervous system; Lateradiation effects; Leukoaraiosis; Leukoencephalopathy; Magnetic resonance imaging; Radiation therapy; Radiation toxicity

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIOGRAPHY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DOSE RESPONSE; FEMALE; HUMAN; LEUKOARAIOSIS; LEUKOENCEPHALOPATHY; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RISK FACTOR; SURVIVAL TIME; WHITE MATTER; WHOLE BRAIN RADIATION THERAPY; ADOLESCENT; BRAIN TUMOR; INCIDENCE; METASTASIS; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; INCIDENCE; LEUKOARAIOSIS; MALE; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38449104420     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0108-2     Document Type: Article

References (26)

1. Madajewicz S, Karakousis C, West CR et al (1984) Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 53:2550-2552
2. Chao JH, Phillips R, Nickson JJ (1954) Roentgen-ray therapy of cerebral metastases. Cancer 7:682-689
3. Carella RJ, Gelber R, Hendrickson F et al (1980) Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II. Cancer 45:679-683
4. Buchsbaum JC, Suh JH, Lee S-Y et al (2002) Survival by Radiation Therapy Oncology Group Recursive Partitioning Analysis Class and treatment modality in patients with brain metastases from malignant melanoma. A retrospective study. Cancer 94:2265-2272
5. Franke W, Neumann N, Richter-Hintz D et al (2000) Temozolomide - A promising agent in the therapy of brain metastases in malignant melanoma. In: American Society of Clinical Oncology 36th Annual Meeting, New Orleans, 20-23 May. Prog Proc Am Soc Clin Oncol 19:575
6. Biasco G, Pantaleo MA, Casadei S (2001) Treatment of brain metastases of malignant melanoma with temozolomide. N Engl J Med 345:621
7. Conill C, Puig S, Toscas I, Castel T (2002) Complete response of cerebral metastatic melanoma after a combined treatment of radiotherapy and temozolomide. Med Clin (Barc) 119:758-759
8. Conill C, Fernandez-Ibiza J, Malvehy J et al (2004) Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation. Med Clin (Barc) 122:413-415
9. Crossen JR, Garwood D, Glastein E, Neuwelt EA (1994) Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 12:627-642
10. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of nitrogen mustards in the palliative treatment of cancer. Cancer 1:634-656
11. Conill C, Verger E, Salamero M (1990) Performance status assessment in cancer patients. Cancer 65:1864-1866
12. Gaspar LE, Scott Ch, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001-1006
13. Zimmerman RD, Fleming CA, Lee BCP et al (1986) Periventricular hyperintensity as seen by magnetic resonance: Prevalence and significance. AJNR Am J Neuroradiol 7:13-20
14. Tsuruda JS, Kortman KE, Bradley WG et al (1987) Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 1987; 149:165-71
15. Vigliani MC, Duyckaerts C, Hauw JJ et al (1999) Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: A clinical and pathological study. J Neuro-Oncol 41:137-149
16. Corn BW, Yousem DM, Scott CB et al (1994) White matter changes are correlated significantly with radiation dose. Cancer 74:2828-2835
17. Asai A, Matsutani M, Kohno T et al (1989) Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63:1962-1974
18. DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796
19. Hochberg FH, Slotnick B (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30:172-177
20. Fisher B, Seiferheld W, Schultz Ch et al (2005) Secondary analysis of Radiation Oncology Group Study (RTOG) 9310: An intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neuro-Oncol 74:201-205
21. Johnson BE, Becker B, Goff WB et al (1985) Neurologic, neuropsychologic, and computed tomography scan abnormalities in 2 to 10-year survivors of small cell carcinoma lung cancer. J Clin Oncol 3:1659-1667
22. Curran WJ, Hecht-Leavitt C, Schut L et al (1987) Magnetic resonance imaging of cranial radiation lesions. Int J Radiat Oncol Biol Phys 13:1093-1098
23. Regine WF, Scott C, Murray K, Curran W (2001) Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51:711-717
24. Shibamoto Y, Baba F, Oda K et al (2006) Incidence of brain atrophy and dementia after whole-brain radiotherapy in patients with brain metastases: A prospective study. Int J Radiat Oncol Biol Phys 66[Suppl 1]:S86-S87
25. Wassenberg MW, Bromberg JE, Witkamp TD et al (2001) White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma. J Neurooncol 52:73-80
26. Gruss C, Geissler A, Schalke B et al (2002) Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation. Melanoma Res 12:403-404